Three months of dietary supplementation with flaxseed lowered total and low-density lipoprotein cholesterol levels.
Three months of dietary supplementation with flaxseed, 30 g/d, lowered the total and low-density lipoprotein cholesterol (LDL-C) levels of Native American postmenopausal women by approximately 7% and 10%, respectively.
Researchers from Oklahoma, Arkansas, and Florida included 55 mildly to moderately hypercholesterolemic (≥5.1 to ≤9.8 mmol/L) Native American postmenopausal women in the study. The flaxseed provided was incorporated into baking products, such as breads and muffins, rather than consumed as a whole ground food, on the belief that the cholesterol lowering effects of flaxseed are enhanced by the high temperatures associated with baking.
No statistically significant changes in high-density lipoprotein (HDL) or triglyceride levels occurred; however, triglyceride concentrations in the flaxseed group increased insignificantly, suggesting that the n-3 fatty acid in flaxseed, unlike that of fish oil, is ineffective in lowering triglyceride levels. Flaxseed also lowered Lp(a), an independent predictor of atherosclerosis, by 22%, although the mean values did not reach statistical significance. Flaxseed had no effect on hematologic parameters, such as white or red blood cell counts or hemoglobin concentrations, but it did increase monocyte percentage, which theoretically leads to greater uptake of cholesterol from plasma and more plaque formation. And it had no effect on serum levels of C-reactive protein or on estrogen or FSH levels.
Patade A, Devareddy L, Lucas EA, et al. Flaxseed reduces total and LDL cholesterol concentrations in Native American postmenopausal women. J Womens Health (Larchmt). 2008;17:355-366.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More